Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Cutting edge: membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection.
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
Pelger-Huet Anomaly
Vascular Diseases
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis. J Am Acad Dermatol. 2006 Apr; 54(4 Suppl 1):S164-70.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Chronic Disease
Female
Humans
Immunologic Factors
Male
Middle Aged
Patient Satisfaction
Psoriasis
Retreatment
Treatment Outcome
authors with profiles
Kenneth Gordon